AvoCog - the Effect of Daily Avocado Intake on Cognitive Function in Older Adults
AvoCog
AvoCog - The Effect of Daily Avocado Intake on Cognitive Function in Older Adults
1 other identifier
interventional
70
1 country
1
Brief Summary
The goal of this clinical trial is to determine if adding avocados to the diet of impacts cognition in 70 older adults, age 65-85, without dementia. We will test for change in functional MRI, cognitive performance, and brain blood flow. Intervention group participants will be asked to consume 1 avocado per day for 12 weeks. Participants in the control group will be asked to continue their normal intake for 12 weeks. Throughout the study, participants will be asked to perform cognitive tests, MRI, blood tests, and questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 13, 2023
CompletedFirst Posted
Study publicly available on registry
November 18, 2023
CompletedStudy Start
First participant enrolled
April 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedAugust 22, 2024
August 1, 2024
1.6 years
November 13, 2023
August 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in brain activity
MRI will be used to measure changes in brain activity during resting state, a working memory task, and executive function task.
Baseline and 12 weeks
Secondary Outcomes (2)
Changes in cerebral blood flow
Baseline and 12 weeks
Changes in memory and executive function
Baseline and 12 weeks
Study Arms (2)
Avocado Group
EXPERIMENTALParticipants will consume 1 avocado per day and receive education to maintain usual caloric intake for 12 weeks and participate in 4 study visits.
No Diet Modification Group
NO INTERVENTIONParticipants will continue their normal dietary pattern for 12 weeks and participate in 4 study visits.
Interventions
Participants will consume provided avocados daily and track consumption for the duration of the study. Participants will be adding avocados to their diet and will receive education on maintaining usual diet.
Eligibility Criteria
You may qualify if:
- Males and females aged 65-85 years
- Good general health with no concomitant disease
- BMI 18.5 - 35 kg/m2
- Mini Mental State Exam ≥26
- Reports consuming ≤2 medium avocados per month
- Reports consuming ≤3 servings of carotenoid-rich foods per week and ≤3 servings of fruits and vegetables per day
- Skin carotenoid content \<400
You may not qualify if:
- Unwilling or unable to consume avocado
- Latex allergy
- Consistently taking lutein + zeaxanthin supplements
- Skin carotenoid content ≥400
- Central neurological disease such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, stroke, brain tumor, etc.
- Serious medical risk: cancer requiring chemotherapy or radiation within the past 5 years, recent cardiac event (i.e. heart attack, etc.)
- Diabetes mellitus or uncontrolled hypertension
- Use of psychoactive or investigational medications
- Consumption of ≥3 alcoholic drinks per day or substance abuse
- Unable to undergo MRI
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Kansas Medical Centerlead
- Avocado Nutrition Centercollaborator
Study Sites (1)
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Participants cannot be blinded to their allocation in order to follow the study protocol. Investigator and Outcomes Assessor will be blinded.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. Matthew K Taylor, PhD, RD
Study Record Dates
First Submitted
November 13, 2023
First Posted
November 18, 2023
Study Start
April 9, 2024
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
August 22, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share